Today’s Solutions: April 07, 2025

Are we on the brink of a psychedelic revolution? It’s seeming more and more likely. A scientific review of the existing research into the therapeutic applications of psychedelics, published in the Canadian Medical Association Journal, highlights the enormous potential of substances like LSD, psilocybin (hallucinogenic mushrooms) and MDMA (the active ingredient in Ecstasy) for treating a host of mental health issues, including post-traumatic stress disorder, addiction, anxiety associated with terminal illness and depression. “The studies are showing big effects,” Matthew Johnson, a behavioral pharmacologist at Johns Hopkins University and one of the study’s authors, told The Huffington Post. “The exciting thing isn’t just that these drugs work for something that we already have treatment for. It’s that they’re getting big effects on disorders for which we have very poor treatment.”

Solutions News Source Print this article
More of Today's Solutions

Finland races ahead in clean energy: coal phase-out arrives four years early

  In a remarkable step toward a fossil-free future, Finland has effectively phased out coal as a source of electricity generation—four years ahead of ...

Read More

Antarctic fossil reveals clues about the oldest known modern bird

  At the dramatic close of the Cretaceous Period, 66 million years ago, an asteroid slammed into Earth's Yucatán Peninsula, wiping out most dinosaurs. ...

Read More

Panama enacts landmark legislation giving Nature rights

Panama is among the 25 most megadiverse countries in the world. It is home to big cats like jaguars and ocelots, 6 distinct monkey ...

Read More

Study reveals how ketamine fights depression

We have previously reported on a story about ketamine’s potential to help fight depression. Now, we'd like to preset you to some study findings ...

Read More